TOPIRAMATE | A206210 | ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Highest NADAC/Unit
$23.21
per ea
Lowest NADAC/Unit
$3.83
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00480235901TOPIRAMATE ER 200 MG CAPSULE | $23.21 | EA | Generic | — | 2026-06-17 |
| 00480235956TOPIRAMATE ER 200 MG CAPSULE | $23.21 | EA | Generic | — | 2026-06-17 |
| 00480235801TOPIRAMATE ER 100 MG CAPSULE | $10.76 | EA | Generic | — | 2026-06-17 |
| 00480235856TOPIRAMATE ER 100 MG CAPSULE | $10.76 | EA | Generic | — | 2026-06-17 |
| 00480235701TOPIRAMATE ER 50 MG CAPSULE | $6.27 | EA | Generic | — | 2026-06-17 |
| 00480235756TOPIRAMATE ER 50 MG CAPSULE | $6.27 | EA | Generic | — | 2026-06-17 |
| 00480235656TOPIRAMATE ER 25 MG CAPSULE | $3.83 | EA | Generic | — | 2026-06-17 |
| 00480235601TOPIRAMATE ER 25 MG CAPSULE | $3.83 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.